Overall rank by patents
#49,019
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene).
The verdict
According to USPTO PatentsView, Neoss ranks #49,019 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R49019 · Foreign Corporation #49,019 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Neogenis Labs, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Neoss · this assignee
32 score
3D Lighting… · lowest
7 score
What this shows Neoss's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Neoss Limited is a focused PatentsView assignee: 5 CPC subclasses with 60% of grants classified under A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2016. By volume, Neoss sits between Neogenis Labs, Inc. and Netra Systems, Inc.
Neoss Limited shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Neogenis Labs, Inc.
5 patents
Neomend, Inc.
5 patents
Neores AB
5 patents
Neosinus Health Inc.
5 patents
Nercon Eng. & Mfg., Inc.
5 patents
Net Insight AB
5 patents
Netduma Software, Ltd.
5 patents
Netra Systems, Inc
5 patents
Neoss Limited
5 patents
What this shows Neoss holds 5 patents at rank #49,138, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,138 in granted patent volume.
Other assignees with the most granted patents in Neoss's primary technology class.
Neoss's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2019 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Top 5 of 5 technology areas
Overall rank by patents
#49,019
of 49,997 tracked assignees
31.9 out of 100
What to do with this data
Neoss Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.